Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2050-6511
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation ; volume:19 ; number:1 ; day:27 ; month:3 ; year:2018 ; pages:1-9 ; date:12.2018
BMC pharmacology & toxicology ; 19, Heft 1 (27.3.2018), 1-9, 12.2018

Urheber
Eaton, Natalie
Beteiligte Personen und Organisationen
Cabanas, Hélène
Balinas, Cassandra
Klein, Anne
Staines, Donald
Marshall-Gradisnik, Sonya
SpringerLink (Online service)

DOI
10.1186/s40360-018-0203-8
URN
urn:nbn:de:101:1-2018053100011212000030
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:35 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Eaton, Natalie
  • Cabanas, Hélène
  • Balinas, Cassandra
  • Klein, Anne
  • Staines, Donald
  • Marshall-Gradisnik, Sonya
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients

Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?

Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population

Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population

Verbundene Objekte